Published in Hypertension on December 01, 1991
Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure. J Clin Invest (1996) 1.10
Evidence for the involvement of different receptor subtypes in the pre- and postjunctional actions of angiotensin II at rat sympathetic neuroeffector sites. Br J Pharmacol (1995) 0.86
Role of angiotensin II in dietary modulation of rat late distal tubule bicarbonate flux in vivo. J Clin Invest (1996) 0.85
Immunohistochemical Localization of AT1a, AT1b, and AT2 Angiotensin II Receptor Subtypes in the Rat Adrenal, Pituitary, and Brain with a Perspective Commentary. Int J Hypertens (2013) 0.85
The acetylene-ethylene assay for n(2) fixation: laboratory and field evaluation. Plant Physiol (1968) 28.49
Interstitial brain adenosine and xanthine increase during jugular venous oxygen desaturations in humans after traumatic brain injury. Crit Care Med (2001) 1.59
Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression, and gene chromosomal assignment. FASEB J (1991) 1.54
Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production. Neuroscience (2006) 1.53
Increased adenosine in cerebrospinal fluid after severe traumatic brain injury in infants and children: association with severity of injury and excitotoxicity. Crit Care Med (2001) 1.52
Clinical implications of prostaglandin and thromboxane A2 formation (1). N Engl J Med (1988) 1.45
Nitric oxide inhibits angiotensin II-induced migration of rat aortic smooth muscle cell. Role of cyclic-nucleotides and angiotensin1 receptors. J Clin Invest (1995) 1.34
Estrogen-induced cardiorenal protection: potential cellular, biochemical, and molecular mechanisms. Am J Physiol Renal Physiol (2001) 1.33
Adenosine inhibits collagen and protein synthesis in cardiac fibroblasts: role of A2B receptors. Hypertension (1998) 1.31
Exogenous and endogenous adenosine inhibits fetal calf serum-induced growth of rat cardiac fibroblasts: role of A2B receptors. Circulation (1997) 1.24
Teaching clinical pharmacology and therapeutics: selective for fourth-year medical students. J Clin Pharmacol (1998) 1.22
Decreased expression of Kv4.2 and novel Kv4.3 K+ channel subunit mRNAs in ventricles of renovascular hypertensive rats. Circ Res (1997) 1.20
Clinical implications of prostaglandin and thromboxane A2 formation (2). N Engl J Med (1988) 1.19
A(2b) receptors mediate the antimitogenic effects of adenosine in cardiac fibroblasts. Hypertension (2001) 1.18
Adenosine inhibits growth of human aortic smooth muscle cells via A2B receptors. Hypertension (1998) 1.15
A(2B) receptors mediate antimitogenesis in vascular smooth muscle cells. Hypertension (2000) 1.15
The in situ blood perfused rat mesentery; a model for assessing modulation of adrenergic neurotransmission. Eur J Pharmacol (1980) 1.12
Adenosine inhibits growth of rat aortic smooth muscle cells. Possible role of A2b receptor. Hypertension (1996) 1.09
Effect of aminophylline on renal vasoconstriction produced by amphotericin B in the rat. Naunyn Schmiedebergs Arch Pharmacol (1983) 1.08
Human CD4+ CD39+ regulatory T cells produce adenosine upon co-expression of surface CD73 or contact with CD73+ exosomes or CD73+ cells. Clin Exp Immunol (2014) 1.08
17Beta-estradiol, its metabolites, and progesterone inhibit cardiac fibroblast growth. Hypertension (1998) 1.07
Modulation by angiotensin II of isoproterenol-induced cAMP production in preglomerular microvascular smooth muscle cells from normotensive and genetically hypertensive rats. J Pharmacol Exp Ther (1998) 1.05
Clinically used estrogens differentially inhibit human aortic smooth muscle cell growth and mitogen-activated protein kinase activity. Arterioscler Thromb Vasc Biol (2000) 1.04
Cardiovascular protective effects of 17beta-estradiol metabolites. J Appl Physiol (1985) (2001) 1.04
Endogenous cyclic AMP-adenosine pathway regulates cardiac fibroblast growth. Hypertension (2001) 1.01
Estradiol inhibits smooth muscle cell growth in part by activating the cAMP-adenosine pathway. Hypertension (2000) 1.01
Amphotericin-B nephrotoxicity in humans decreased by sodium supplements with coadministration of ticarcillin or intravenous saline. Klin Wochenschr (1987) 1.00
Effects of long-term caffeine consumption on renal function in spontaneously hypertensive heart failure prone rats. J Cardiovasc Pharmacol (1999) 1.00
Cyclic AMP-adenosine pathway induces nitric oxide synthesis in aortic smooth muscle cells. Hypertension (1998) 1.00
Phytoestrogens inhibit growth and MAP kinase activity in human aortic smooth muscle cells. Hypertension (1999) 1.00
Role of renal prostaglandins in sympathetically mediated renin relase in the rat. J Clin Invest (1979) 1.00
Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol and norethisterone acetate. A two-year follow-up study. Hypertension (1995) 1.00
Metabolism of exogenous cyclic AMP to adenosine in the rat kidney. J Pharmacol Exp Ther (1995) 1.00
Amphotericin B nephrotoxicity in humans decreased by salt repletion. Am J Med (1983) 0.99
Estradiol metabolites inhibit endothelin synthesis by an estrogen receptor-independent mechanism. Hypertension (2001) 0.98
The effects of intravenous infusions of selective adenosine A1-receptor and A2-receptor agonists on myocardial reperfusion injury. Am Heart J (1992) 0.98
Cardiac fibroblasts express the cAMP-adenosine pathway. Hypertension (2000) 0.97
Metabolic disposition of prostacyclin in humans. J Pharmacol Exp Ther (1983) 0.97
Cerebrospinal fluid adenosine concentration and uncoupling of cerebral blood flow and oxidative metabolism after severe head injury in humans. Neurosurgery (1997) 0.97
Cyclic AMP-adenosine pathway inhibits vascular smooth muscle cell growth. Hypertension (1996) 0.97
Caffeine potentiates vasodilator-induced renin release. J Pharmacol Exp Ther (1991) 0.96
Effects of estradiol and its metabolites on glomerular endothelial nitric oxide synthesis and mesangial cell growth. Hypertension (2001) 0.95
Hydrogen reactions of nitrogenase. Formation of the molecule HD by nitrogenase and by an inorganic model. J Biol Chem (1968) 0.95
2-Hydroxyestradiol attenuates the development of obesity, the metabolic syndrome, and vascular and renal dysfunction in obese ZSF1 rats. J Pharmacol Exp Ther (2001) 0.94
Evidence for an endogenous cAMP-adenosine pathway in the rat kidney. J Pharmacol Exp Ther (1998) 0.94
Methoxyestradiols mediate the antimitogenic effects of estradiol on vascular smooth muscle cells via estrogen receptor-independent mechanisms. Biochem Biophys Res Commun (2000) 0.93
Factors controlling growth and matrix production in vascular smooth muscle and glomerular mesangial cells. Curr Opin Nephrol Hypertens (1997) 0.93
Effect of aminophylline on amphotericin B nephrotoxicity in the dog. J Pharmacol Exp Ther (1983) 0.92
Reduction of myocardial reperfusion injury by intravenous adenosine administered during the early reperfusion period. Circulation (1991) 0.91
Attenuation of cisplatinum-induced nephrotoxicity in the rat by high salt diet, furosemide and acetazolamide. Naunyn Schmiedebergs Arch Pharmacol (1985) 0.91
Adenosine inhibits collagen and total protein synthesis in vascular smooth muscle cells. Hypertension (1999) 0.91
Inhibition of type IV phosphodiesterase by Ro 20-1724 attenuates endotoxin-induced acute renal failure. J Pharmacol Exp Ther (1996) 0.91
Brain uptake of benzodiazepines: effects of lipophilicity and plasma protein binding. J Pharmacol Exp Ther (1988) 0.90
A possible antihypertensive mechanism of propranolol: antagonism of angiotensin II enhancement of sympathetic nerve transmission through prostaglandins. Hypertension (1981) 0.90
Perfusion quantitation in transplanted rat kidney by MRI with arterial spin labeling. Kidney Int (1998) 0.90
Pertussis toxin-sensitive G-proteins and regulation of blood pressure in the spontaneously hypertensive rat. Clin Exp Pharmacol Physiol (1999) 0.90
Enhanced renal angiotensin II subtype 1 receptor responses in the spontaneously hypertensive rat. Hypertension (1993) 0.90
Ultrasound findings of masses of the paratesticular space. Clin Radiol (2007) 0.89
Effects of selective A1 receptor blockade on glomerular hemodynamics: involvement of renin-angiotensin system. Am J Physiol (1994) 0.89
Sodium status influences chronic amphotericin B nephrotoxicity in rats. Antimicrob Agents Chemother (1989) 0.89
Modulation of adrenergic transmission by angiotensins in the perfused rat mesentery. Am J Physiol (1979) 0.89
6-Keto-prostaglandin E1 is more potent than prostaglandin I2 as a renal vasodilator and renin secretagogue. J Pharmacol Exp Ther (1981) 0.88
Cyclooxygenase inhibition reveals synergistic action of vasoconstrictors on mesangial cell growth. Eur J Pharmacol (1998) 0.88
Estrogen and tamoxifen metabolites protect smooth muscle cell membrane phospholipids against peroxidation and inhibit cell growth. Circ Res (1999) 0.88
Smooth muscle cell-derived adenosine inhibits cell growth. Hypertension (1996) 0.87
Hemodynamic effects of adenosine in conscious hypertensive and normotensive rats. Hypertension (1986) 0.87
Climate change, human health, and sustainable development. Bull World Health Organ (1997) 0.87
Application of the fast-evaporation sample preparation method for improving quantification of angiotensin II by matrix-assisted laser desorption/ionization. Rapid Commun Mass Spectrom (1995) 0.87
Angiotensin II signaling to phospholipase D in renal microvascular smooth muscle cells in SHR. Hypertension (2001) 0.87
Assessment of the extent to exogenous prostaglandin I2 is converted to 6-keto-prostaglandin E1 in human subjects. J Pharmacol Exp Ther (1982) 0.87
3-isobutyl-1-methylxanthine decreases renal cortical interstitial levels of adenosine and inosine. Life Sci (1994) 0.86
Sustained reduction in myocardial reperfusion injury with an adenosine receptor antagonist: possible role of the neutrophil chemoattractant response. J Pharmacol Exp Ther (2000) 0.85
Caffeine enhances the slow-pressor response to angiotensin II in rats. Evidence for a caffeine-angiotensin II interaction with the sympathetic nervous system. J Clin Invest (1987) 0.85
Role of adenosine A(1) receptors in modulating extracellular adenosine levels. J Pharmacol Exp Ther (1999) 0.85
Effects of thromboxane synthase inhibition on vascular responsiveness in the in vivo rat mesentery. J Clin Invest (1985) 0.84
Adenosine attenuates reperfusion injury following regional myocardial ischaemia. Cardiovasc Res (1993) 0.84
Diuretic response to adenosine A(1) receptor blockade in normotensive and spontaneously hypertensive rats: role of pertussis toxin-sensitive G-proteins. J Pharmacol Exp Ther (2000) 0.83
An experimental paradigm for investigating the role of endogenous adenosine/A1 receptor interactions in vivo. J Pharmacol Exp Ther (1992) 0.83
Acute renal artery constriction increases renal prostaglandin I2 biosynthesis and renin release in the conscious dog. J Pharmacol Exp Ther (1982) 0.83
The effect of halothane on morphine disposition: relative contributions of the liver and kidney to morphine glucuronidation in the dog. Anesthesiology (1990) 0.83
Comparison of the pulmonary, hepatic and renal extraction of PGI2 and 6-keto-PGE1. Eur J Pharmacol (1982) 0.83
The inhibitory effect of angiotensin II on stimulus-induced release of cAMP is augmented in the genetically hypertensive rat kidney. J Pharmacol Exp Ther (1996) 0.83
Chronic caffeine administration exacerbates renovascular, but not genetic, hypertension in rats. J Clin Invest (1986) 0.83
Low dose intrarenal infusions of PGE2, PGI2, and 6-keto-PGE1 vasodilate the in vivo rat kidney. Circ Res (1982) 0.82
Increased 2-methoxyestradiol production in human coronary versus aortic vascular cells. Hypertension (2001) 0.82
Angiotensin II: enhanced renal responsiveness in young genetically hypertensive rats. J Pharmacol Exp Ther (1995) 0.82
Effects of short-term beta blockade on blood pressure, plasma thromboxane B2, and plasma and urinary prostaglandins E2 and F2 alpha in normal subjects. Clin Pharmacol Ther (1982) 0.82
Aminophylline inhibits renal vasoconstriction produced by intrarenal hypertonic saline. J Pharmacol Exp Ther (1983) 0.82
Effect of indomethacin on hydralazine-induced renin and catecholamine release in the conscious rabbit. Br J Pharmacol (1980) 0.81
Attenuation of the development of hypertension in spontaneously hypertensive rats by the thromboxane synthetase inhibitor, 4'-(imidazol-1-yl) acetophenone. Prostaglandins (1982) 0.81
Treatment with the type IV phosphodiesterase inhibitor Ro 20-1724 protects renal and mesenteric blood flow in endotoxemic rats treated with norepinephrine. J Pharmacol Exp Ther (1996) 0.81
Effect of an adenosine receptor antagonist on acute amphotericin B nephrotoxicity. Eur J Pharmacol (1990) 0.81
Effects of alpha- and beta-adrenoceptor blockade on purine secretion induced by sympathetic nerve stimulation in the rat kidney. J Pharmacol Exp Ther (1999) 0.81
6-keto-prostaglandin EL and Bartter's syndrome. N Engl J Med (1981) 0.80
Vascular reactivity to angiotensin II is selectively enhanced in the kidneys of spontaneously hypertensive rats. J Pharmacol Exp Ther (1994) 0.80
Catecholamines abrogate antimitogenic effects of 2-hydroxyestradiol on human aortic vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (2001) 0.80
Effect of intravenous adenosine on myocardial reperfusion injury in a model with low myocardial collateral blood flow. Am Heart J (1991) 0.80
Endogenous adenosine restrains renin release in conscious rats. Circ Res (1990) 0.80
Beta-adrenoceptor-mediated release of angiotensin II from mesenteric arteries. Am J Physiol (1986) 0.80
Cardiovascular and renal effects of blocking A1 adenosine receptors. J Cardiovasc Pharmacol (1993) 0.80